[Two patients with CC9 intoxication: unexpected symptoms of a novel synthetic cannabinoid].

Summarise with VIRAT
Authors: Denne A. Scharink, Hugo C Hoogeveen, Daan Vlot, Elles Zock, Ankie Lebon, Suzanne Schol‐Gelok
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Hexahydrocannabinol-C9 (CC9) is a novel synthetic cannabinoid with largely unknown toxicity and clinical effects. CASE DESCRIPTION: We report two patients with CC9 intoxication presenting with atypical and prolonged symptoms, including profound somnolence, bradycardia, neuropsychiatric disturbances, and impaired mobility. Both patients experienced a protracted course lasting up to 90 hours. MANAGEMENT: Treatment was primarily focused on symptom control in a low-stimulus environment. Close monitoring of respiratory function was essential in cases of profound sedation, while benzodiazepines were administered when severe agitation occurred. Activated charcoal combined with a laxative was used in one case and may have contributed to recovery by reducing intestinal reabsorption. CONCLUSION: Clinicians should be alert to the atypical and prolonged course of intoxications caused by new synthetic cannabinoids such as CC9. Early recognition, multidisciplinary consultation, and supportive treatment in a low-stimulus environment are essential.

Fields of Study & Subjects

Forensic Toxicology and Drug Analysis Poisoning and overdose treatments Cannabis and Cannabinoid Research

Publication details

Journal / source
PubMed
Volume
170
Publication date
31 March 2026
Language
NL